By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Specialised Therapeutics Australia 

P.O. Box 250

East Kew  Victoria  3102  Australia
Phone: 1300-798-820 Fax: 1800-798-829


SEARCH JOBS








Company News
Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) To Be PBS Listed For Metastatic Pancreatic Cancer 10/31/2014 8:25:27 AM
Alimera Sciences (ALIM) Signs Specialised Therapeutics Australia As Exclusive Iluvien® Distributor For Australia, New Zealand 4/28/2014 9:22:12 AM
Specialised Therapeutics Australia Receives Therapeutic Goods Administration Approval for Brain Tumour Visualisation Drug - Gliolan® 11/11/2013 10:55:23 AM
Specialised Therapeutics Australia Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients 10/25/2012 10:44:05 AM
Optimer Pharmaceuticals, Inc. (OPTR) and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand 6/19/2012 11:52:53 AM
Specialised Therapeutics Australia Release: World Leading Breast Cancer Drug Now Available in New Zealand 2/22/2011 10:41:13 AM
Abraxis BioScience, Inc. and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand 7/29/2010 8:04:43 AM
Abraxis BioScience, Inc. and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia 10/16/2008 10:08:00 AM
//-->